Silvia Huebner, MD
Allergy · Springfield, MONPI 1295711620
Payments from drug & device makers
Across 867 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- CSL Behring$2K
- GSK$1K
- Sanofi$887
- Grifols USA, LLC$728
- Novartis$706
- plus $5K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 213 | $3,624 |
| CSL Behring | 153 | $2,496 |
| GSK | 70 | $1,042 |
| Sanofi | 49 | $887 |
| Grifols USA, LLC | 41 | $728 |
| Novartis | 38 | $706 |
| Pharming Healthcare, Inc. | 40 | $625 |
| Boehringer Ingelheim | 34 | $534 |
| Regeneron Healthcare Solutions, Inc. | 24 | $502 |
| Optinose US, Inc. | 35 | $497 |
| Pfizer | 33 | $477 |
| Amgen | 28 | $461 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $439 |
| Genentech USA, Inc. | 16 | $251 |
| Kaleo, Inc. | 16 | $233 |
| Bio Products Laboratory USA, Inc. | 12 | $176 |
| Teva Pharmaceuticals USA, Inc. | 11 | $160 |
| Incyte Corporation | 4 | $75 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $69 |
| Biocryst US Sales Co., LLC | 3 | $55 |
| Merck | 3 | $49 |
| Alk-abello, Inc | 3 | $43 |
| Octapharma USA, Inc. | 2 | $40 |
| Blueprint Medicines Corporation | 2 | $36 |
| Biocryst Pharmaceuticals, Inc. | 2 | $35 |
| Hikma Pharmaceuticals USA | 2 | $30 |
| ADMA Biomanufacturing LLC | 2 | $27 |
| Shire North American Group Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| LEO Pharma Inc. | 1 | $15 |
| Circassia Inc. | 1 | $12 |
How this compares
Too few allergy providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Springfield
- Robert OnderSaint Louis$5.4M
- Mark VandewalkerColumbia$3M
- Sanchayita TripathyRolla$629K
- Lawrence LandwehrWarrensburg$316K
- Maria SabioKirkwood$15K
- Josie VitaleSaint Louis$10K
- Jeffrey WrightSaint Louis$7K
- Laura EssweinSaint Louis$6K
- William StrickerColumbia$4K
- Douglas BersonChesterfield$929
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.